Erythromycin and Diabetic neuropathy - a phase IV clinical study of FDA data


Diabetic neuropathy is found among people who take Erythromycin, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Erythromycin and have Diabetic neuropathy. It is created by eHealthMe based on reports of 8,894 people who have side effects when taking Erythromycin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 26, 2022

8,894 people reported to have side effects when taking Erythromycin.
Among them, 23 people (0.26%) have Diabetic neuropathy.

What is Erythromycin?

Erythromycin has active ingredients of erythromycin. It is often used in acne. eHealthMe is studying from 9,384 Erythromycin users for its effectiveness, alternative drugs and more.

What is Diabetic neuropathy?

Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus) is found to be associated with 1,475 drugs and 893 conditions by eHealthMe.

Number of Erythromycin and Diabetic neuropathy reports submitted per year:

Could Erythromycin cause Diabetic neuropathy?

Gender of people who have Diabetic neuropathy when taking Erythromycin *:

  • female: 65.22 %
  • male: 34.78 %

Age of people who have Diabetic neuropathy when taking Erythromycin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 37.5 %
  • 50-59: 12.5 %
  • 60+: 50.0 %

Common drugs people take besides Erythromycin *:

  1. Metoclopramide: 10 people, 43.48%
  2. Celebrex: 9 people, 39.13%
  3. Cephalexin: 9 people, 39.13%
  4. Furosemide: 9 people, 39.13%
  5. Albuterol: 8 people, 34.78%
  6. Aspirin: 8 people, 34.78%
  7. Gabapentin: 8 people, 34.78%
  8. Lisinopril: 8 people, 34.78%
  9. Protonix: 7 people, 30.43%
  10. Omeprazole: 7 people, 30.43%

Common side effects people have besides Diabetic neuropathy *:

  1. Breathing Difficulty: 11 people, 47.83%
  2. Joint Pain: 10 people, 43.48%
  3. High Blood Pressure: 9 people, 39.13%
  4. Nausea (feeling of having an urge to vomit): 9 people, 39.13%
  5. Depression: 9 people, 39.13%
  6. Diabetes: 9 people, 39.13%
  7. Pain In Extremity: 9 people, 39.13%
  8. Urinary Tract Infection: 9 people, 39.13%
  9. Weakness: 9 people, 39.13%
  10. Stress And Anxiety: 8 people, 34.78%

Common conditions people have *:

  1. Joint Pain: 2 people, 8.70%
  2. Impaired Gastric Emptying: 2 people, 8.70%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.70%
  4. Type 2 Diabetes: 1 person, 4.35%
  5. Type 1 Diabetes: 1 person, 4.35%
  6. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.35%
  7. Pain: 1 person, 4.35%
  8. Nausea (feeling of having an urge to vomit): 1 person, 4.35%
  9. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 4.35%
  10. Multiple Myeloma (cancer of the plasma cells): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Erythromycin and have Diabetic neuropathy?

Check whether Diabetic neuropathy is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Diabetic neuropathy and when was it recovered:

Expand to all the drugs that have ingredients of erythromycin:

Alternative drugs to, pros and cons of Erythromycin:

Common Erythromycin side effects:

Browse all side effects of Erythromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Diabetic neuropathy treatments and more:

COVID vaccines that are related to Diabetic neuropathy:

Common drugs associated with Diabetic neuropathy:

All the drugs that are associated with Diabetic neuropathy:

Common conditions associated with Diabetic neuropathy:

All the conditions that are associated with Diabetic neuropathy:

How the study uses the data?

The study uses data from the FDA. It is based on erythromycin (the active ingredients of Erythromycin) and Erythromycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: